BG61678B1 - Антиисхемично лекарствено средство - Google Patents

Антиисхемично лекарствено средство Download PDF

Info

Publication number
BG61678B1
BG61678B1 BG99164A BG9916494A BG61678B1 BG 61678 B1 BG61678 B1 BG 61678B1 BG 99164 A BG99164 A BG 99164A BG 9916494 A BG9916494 A BG 9916494A BG 61678 B1 BG61678 B1 BG 61678B1
Authority
BG
Bulgaria
Prior art keywords
tetrahydro
phenyl
methyl
oxo
compound
Prior art date
Application number
BG99164A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99164A (bg
Inventor
Heimo O. Haikala
Jouko M. Levijoki
Reijo J. Baeckstroem
Pentti T. Nore
Erkki J. Honkanen
Original Assignee
Orion-Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion-Yhtymae Oy filed Critical Orion-Yhtymae Oy
Publication of BG99164A publication Critical patent/BG99164A/bg
Publication of BG61678B1 publication Critical patent/BG61678B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
BG99164A 1992-05-06 1994-11-04 Антиисхемично лекарствено средство BG61678B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9209769A GB2266841A (en) 1992-05-06 1992-05-06 Compounds for use as anti-ischemic medicaments
PCT/FI1993/000191 WO1993021921A1 (en) 1992-05-06 1993-05-05 Anti-ischemic medicament

Publications (2)

Publication Number Publication Date
BG99164A BG99164A (bg) 1995-08-28
BG61678B1 true BG61678B1 (bg) 1998-03-31

Family

ID=10715082

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99164A BG61678B1 (bg) 1992-05-06 1994-11-04 Антиисхемично лекарствено средство

Country Status (25)

Country Link
US (1) US5512572A (no)
EP (1) EP0639074B1 (no)
JP (2) JP3313714B2 (no)
KR (1) KR100275823B1 (no)
AT (1) ATE196086T1 (no)
AU (1) AU665840B2 (no)
BG (1) BG61678B1 (no)
BR (1) BR9306314A (no)
CA (1) CA2134972C (no)
CZ (1) CZ283259B6 (no)
DE (1) DE69329381T2 (no)
DK (1) DK0639074T3 (no)
ES (1) ES2150445T3 (no)
FI (1) FI945052A (no)
GB (1) GB2266841A (no)
GR (1) GR3034896T3 (no)
HU (1) HU222349B1 (no)
NO (1) NO306236B1 (no)
NZ (1) NZ252693A (no)
PT (1) PT639074E (no)
RO (1) RO115781B1 (no)
RU (1) RU2146142C1 (no)
SK (1) SK279580B6 (no)
UA (1) UA35584C2 (no)
WO (1) WO1993021921A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI974578A (fi) 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
FI980902A (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI980901A (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI104718B (fi) * 1998-06-18 2000-03-31 Orion Yhtymae Oyj [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä
FI981473A (fi) * 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
GB9915179D0 (en) 1999-06-29 1999-09-01 Orion Corp A method for the treatment or prevention of coronary graft vasospasm
FI109659B (fi) 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
DE60016038T2 (de) 1999-10-22 2005-12-22 Orion Corp. Neue verwendung von levosimendan
FI20001542A (fi) * 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
FI20002526A (fi) * 2000-11-17 2002-05-18 Orion Yhtymae Oyj Pyridatsinonijohdannaisten uusi käyttö
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
JP2002211346A (ja) * 2001-01-15 2002-07-31 Takata Corp インフレータ
FI20010233A0 (fi) 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20020197A0 (fi) * 2002-02-01 2002-02-01 Orion Corp Yhdistelmä akuutin myokardiilisen infarktin hoitoon
US8618316B1 (en) 2004-03-05 2013-12-31 Stepan Company Low temperature ramp rate ester quat formation process
FI20040675A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä sydämen hypertrofian hoitoon ja estoon
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
CN101031302A (zh) * 2004-05-28 2007-09-05 艾博特公司 用于治疗心脏停搏前、期间和之后的哺乳动物的方法
WO2012093404A2 (en) 2011-01-03 2012-07-12 Gufic Biosciences Limited Parenteral formulations of levosimendan
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962110A (en) * 1985-03-12 1990-10-09 Smith Kline & French Laboratories Limited Pyridazinone derivatives
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
FI884418A (fi) * 1987-10-05 1989-04-06 Fujisawa Pharmaceutical Co Hjaertskyddande aemne och ett terapeutiskt aemne foer ischemiska sjukdomar omfattande n-innehaollande heterocykliska foereningar, och ett foerfarande foer framstaellning av dessa foereningar.
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5109575A (en) * 1991-06-10 1992-05-05 Signode Corporation Toothed seal for hard thermoplastic strap

Also Published As

Publication number Publication date
KR100275823B1 (ko) 2001-03-02
FI945052A0 (fi) 1994-10-27
FI945052A (fi) 1994-10-27
AU4262793A (en) 1993-11-29
ATE196086T1 (de) 2000-09-15
DE69329381D1 (de) 2000-10-12
CZ283259B6 (cs) 1998-02-18
CA2134972A1 (en) 1993-11-11
KR950701223A (ko) 1995-03-23
ES2150445T3 (es) 2000-12-01
NO944145L (no) 1994-10-31
CZ272094A3 (en) 1995-02-15
PT639074E (pt) 2001-03-30
RO115781B1 (ro) 2000-06-30
HUT68956A (en) 1995-08-28
BR9306314A (pt) 1998-06-30
RU94046070A (ru) 1996-09-20
GB9209769D0 (en) 1992-06-17
HU9403191D0 (en) 1995-02-28
AU665840B2 (en) 1996-01-18
JP3313714B2 (ja) 2002-08-12
US5512572A (en) 1996-04-30
GR3034896T3 (en) 2001-02-28
EP0639074B1 (en) 2000-09-06
GB2266841A (en) 1993-11-17
NO306236B1 (no) 1999-10-11
SK132494A3 (en) 1995-11-08
UA35584C2 (uk) 2001-04-16
SK279580B6 (sk) 1999-01-11
EP0639074A1 (en) 1995-02-22
JPH07506354A (ja) 1995-07-13
HU222349B1 (hu) 2003-06-28
DK0639074T3 (da) 2000-10-09
DE69329381T2 (de) 2001-04-26
RU2146142C1 (ru) 2000-03-10
JP2002275067A (ja) 2002-09-25
CA2134972C (en) 2004-07-20
BG99164A (bg) 1995-08-28
WO1993021921A1 (en) 1993-11-11
NZ252693A (en) 1997-07-27
NO944145D0 (no) 1994-10-31

Similar Documents

Publication Publication Date Title
BG61678B1 (bg) Антиисхемично лекарствено средство
Muller et al. Nifedipine therapy for Prinzmetal's angina.
Reimer et al. Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.
JPH0649651B2 (ja) 心筋虚血治療用医薬組成物
KR20160108611A (ko) 심방세동의 치료 방법
CN1043509C (zh) 抗氧剂羟基咔唑化合物的制药用途
JP2009500365A (ja) 再灌流障害を処置するための可溶性グアニル酸シクラーゼ活性化剤の使用
CZ298745B6 (cs) Farmaceutická kombinace, farmaceutický přípravek, způsob jeho výroby a použití kombinace
Stone et al. Nifedipine therapy for recurrent ischemic pain following myocardial infarction
EP0412901A2 (fr) Utilisation de trifluorométhyl-phényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles de la motricité intestinale
KR930001105B1 (ko) 심부정맥 예방 또는 치료용약제
HU212941B (en) Process for producing synergetic, antihypertensive pharmaceutical compositions containing verapamil and trandolapril
WO2000025773A1 (en) Pharmaceutical combination of mildronate and enalapril
EA004142B1 (ru) Способ лечения или профилактики вазоспазма коронарного трансплантата
JP6336484B2 (ja) 遅延ナトリウム電流遮断薬および洞房結節ｉｆ電流阻害薬の組合せ、ならびに該組合せを含む医薬組成物
JPH01283224A (ja) 抗高血圧の組み合わせ調合物
HU212502B (en) Process for producing pharmaceutical preparative containing n-methyl-2-(3-pyridyl)-tetrahydrothiopyrane-2-carbothioamide-1-oxide applicable for treating insufficiency of coronary arteries
REIMER et al. Effect of the Calcium Antagonist Verapamil on Necrosis following Temporary Coronary Artery
HUT52384A (en) Process for producing pharmaceutical compositions comprising dianhydrohexitol acyl derivatives